Very nice, Change! It would be great if Lifeline, which is the publicly traded entity of Cyrcadia, would be more proactive in providing the same information to its shareholders. As a large percentage owner of Cyrcadia, Lifeline shareholders are entitled to these updates but I'm glad you relayed it to us!

The Cyrcadia Asia deal is incredibly positive for all concerned since, basically, they are providing the funds that Cyrcadia, Inc. will be funneling to Lifeline as payment for licensing and patents. No financial burden for CI but Lifeline will be able to pay off liabilities and enjoy future success. Then, all the start-up manufacturing and sales, and more importantly AI gleaned with the software on patients in Asia initially, will benefit the US launch. Even though they haven't been stellar with deadlines and communication, 2018 is looking like go-time and the beginning of profitability on all aspects of the long history of this technology development! The time is now! If only I had more free money to soak up shares at the current level!

Thanks again!!